Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Natural Killer Cells in Covid-19: From Infection, to Vaccination and Therapy Publisher



Zafarani A1 ; Razizadeh MH2 ; Pashangzadeh S3, 4 ; Amirzargar MR1 ; Taghavifarahabadi M5 ; Mahmoudi M6
Authors

Source: Future Virology Published:2023


Abstract

Natural killer (NK) cells are among the most important innate immunity members, which are the first cells that fight against infected cells. The function of these cells is impaired in patients with COVID-19 and they are not able to prevent the spread of the disease or destroy the infected cells. Few studies have evaluated the effects of COVID-19 vaccines on NK cells, though it has been demonstrated that DNA vaccines and BNT162b2 can affect NK cell response. In the present paper, the effects of SARS-CoV-2 on the NK cells during infection, the effect of vaccination on NK cells, and the NK cell-based therapies were reviewed. © 2023 Future Medicine Ltd.
Related Docs
View other Related Docs
1. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
2. Unraveling the Dynamic Mechanisms of Natural Killer Cells in Viral Infections: Insights and Implications, Virology Journal (2024)
3. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Azadeh Omidkhoda (1)
Other Related Docs
4. Natural Killer Cells and Their Exosomes in Viral Infections and Related Therapeutic Approaches: Where Are We?, Cell Communication and Signaling (2023)
5. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
6. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
7. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
8. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
9. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
10. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
11. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
12. Immunoediting in Sars-Cov-2: Mutual Relationship Between the Virus and the Host, International Immunopharmacology (2022)
13. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
14. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
15. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
16. The Role of Inflammation in the Development of Complications Caused by Covid-19: A Review Study, Journal of Payavard Salamat (2022)
17. Complement Inhibition: A Possible Therapeutic Approach in the Fight Against Covid-19, Reviews in Medical Virology (2022)
18. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
19. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
20. The Emerging Role of Probiotics As a Mitigation Strategy Against Coronavirus Disease 2019 (Covid-19), Archives of Virology (2021)